BREGAL-MILESTONE
Bregal Milestone, a leading European technology and software private equity firm, is pleased to announce the acquisition of Aktieinvest Incentives by its portfolio company, Allshares, a pioneering compensation and long-term incentive software and services provider. Following Allshares’ recent acquisition of Novare Pay, the strategic addition of Aktieinvest Incentives further establishes the company at the forefront of providing comprehensive compensation and incentive solutions in Sweden.
Aktieinvest Incentives is a leading provider of share plan and equity incentive administration to business customers in Sweden. Following the acquisition, Aktieinvest Incentives will fully integrate with Allshares’ state-of-the-art equity plan administration platform. Current Aktieinvest Incentives customers can expect uninterrupted service and will benefit from Allshares’ exceptional client support and end-to-end solutions, including expanded offerings like tax services and IFRS reporting.
In a statement from Louise Hagsten, CEO of Aktieinvest Incentives, the decision to integrate with Allshares was underscored by its unmatched holistic software and services offering. "Our partnership with Allshares heralds a new era of innovation and client-centricity for Aktieinvest Incentives customers. We were drawn to Allshares' commitment to excellence and their robust equity plan administration product suite which includes tax and IFRS reporting capabilities. We are confident that joining forces with Allshares will translate to an enhanced digital participant experience for Aktieinvest Incentives’ customers."
Erika Andersson, former CEO of Novare Pay and recently appointed CEO of Allshares Sweden, stated, “The reception of Allshares by Novare Pay customers and the broader Swedish market has been overwhelmingly positive. I am confident that Aktieinvest Incentives’ customers will have a similar experience, thanks to Allshares’ customer-centric and innovative approach to compensation solutions. The Allshares proposition stands out in the market, and I am eager to maintain our longstanding relationship with Aktieinvest Incentives’ customers. With Allshares, we can offer an enhanced equity plan administration proposition, further improving our ability to serve customers effectively.”
Pertti Helaniemi, CEO of Allshares Finland, highlighted the continuity and seamless experience that customers can expect from the addition of Aktieinvest Incentives to the Allshares ecosystem. "At Allshares, we are dedicated to maintaining high standards of service and innovation. In addition to Allshares’ comprehensive equity plan administration platform, our Pay Incentives, Pay Governance and Pay Analytics service offerings mean clients can expect a seamless one-stop experience for all their compensation needs."
John Hales, Managing Director at Bregal Milestone, reiterated the company's vision and the integral role that Aktieinvest Incentives plays in achieving it. "At Allshares, the vision is to deliver leading compensation solutions that drive high performance for both private and publicly listed customers throughout Europe. The acquisition of Aktieinvest Incentives is a testament to our commitment to this vision, as it strengthens our position as a leader in the Nordic region and reinforces our ability to deliver exceptional value to leading companies. We are thrilled to welcome Aktieinvest Incentives to the Allshares family and look forward to leveraging our combined strengths to deliver distinctive compensation solutions."
Terms of the transaction were not disclosed and are subject to customary closing conditions.
About Bregal Milestone
Bregal Milestone is a leading European software and technology private equity firm with c.€1.3 billion of capital raised since inception. The firm provides growth capital and operational support to build market-leading technology companies. Bregal Milestone is part of Bregal Investments, a leading global investment platform with assets under management of over €18 billion. Bregal Milestone was recognised by GrowthCap as one of the Top Growth Equity Firms of 2023. For more information, visit www.bregalmilestone.com or follow us on LinkedIn.
About Allshares
Allshares is a pioneering provider of compensation and incentive solutions in Europe. Trusted by leading multinational enterprises, Allshares will now serve approximately 900 clients in more than 60 countries with an end-to-end digital turnkey solution for equity plan management. Companies and participants can use its proprietary software and services to administer share plans in full compliance with relevant regulations, legal, and tax frameworks, as well as deliver seamless and automated IFRS reporting of share plans to companies. For more information, visit www.allshares.com.
About Aktieinvest
Aktieinvest Incentives is a part of Aktieinvest. Aktieinvest, among Sweden's oldest online brokers, boasts a 50-year legacy and 60,000 customers. Aktieinvest offers monthly share savings, dividend reinvestment, and handles corporate events, essentially simplifying stock investment. With a workforce of around 40, and a customer-centric approach, Aktieinvest has consistently sought to modernize and enhance its offerings, ensuring that clients can seamlessly save and invest in both Swedish and foreign stocks, funds, and ETFs. Since June 2023, Aktieinvest has been under the ownership of Söderberg & Partners, a prominent financial advisor and intermediary in the Nordic region. For more information, visit www.allshares.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240514298200/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma18.12.2025 12:00:00 CET | Press release
BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancerFDA Fast Track Designation reflects the potential of BGB-B2033 in an area of high unmet need BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company Fast Track Designation for BGB-B2033, its GPC3x4-1BB bispecific antibody for the treatment of adult patients with hepatocellular carcinoma (HCC) with disease progression on or after prior systemic treatment. “The FDA awards Fast Track Designation to therapies that show potential to address an unmet medical need in serious or life-threatening conditions. The FDA’s decision reflects the encouraging profile of BGB-B2033 in advanced hepatocellular carcinoma, where patients continue to face limited treatment options,” said Julie Lepin, Senior Vice President and Chief Regulatory Affairs Officer at BeOne. BeOne is currentl
NHOA Energy Achieves Great Place To Work Certification in Italy, the United States and Australia18.12.2025 10:53:00 CET | Press release
NHOA Energy, global provider of utility-scale energy storage systems, announces that it has been certified Great Place To Work® in Italy, the United States, and Australia. The certification is based entirely on direct feedback from NHOA Energy employees, gathered through an independent and structured listening process. Great Place To Work® Certification™ assesses the quality of the employee experience across key dimensions such as credibility, respect, fairness, pride, and camaraderie. The results achieved by NHOA Energy reflect a corporate culture built on trust, inclusion, and the consistent commitment to valuing people within a dynamic and international environment. Employees highlighted particularly high levels of appreciation for the ethical and transparent behavior of leaders, the welcoming and inclusive approach toward new hires, and fair treatment across diversity, equity, and inclusion dimensions. A strong majority also expressed pride in working at NHOA Energy and reported a
Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press release
The deal further strengthens Regnology’s global position in Regulatory Reporting and significantly accelerates its expansion into new markets Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeki
Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press release
Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press release
Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear skin (PASI 90), and on average about 30 percent achieved completely clear skin (PASI 100) by week 16 Zasocitinib was generally well-tolerated with a safety profile consistent with previous clinical studies Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at wee
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom